» Articles » PMID: 20595471

Lack of Active Onchocerca Volvulus Transmission in the Northern Chiapas Focus of Mexico

Overview
Specialty Tropical Medicine
Date 2010 Jul 3
PMID 20595471
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The northern Chiapas onchocerciasis focus has undergone 11 years of ivermectin mass treatment. No evidence of microfilariae in the cornea and/or anterior chamber of the eye or in skin snips was seen in residents examined in 2006 in two sentinel communities (upper limit of the 95% confidence interval [UL 95% CI] = 0.5% and 0.3%, respectively). In children 10 and under, 0 of 305 were found to harbor antibodies to Ov16, a marker of parasite exposure; 0 of 4,400 Simulium ochraceum s.l. collected in 2005 contained parasite DNA, giving an UL 95% CI for the infective rate of 0.9/2,000, and an UL 95% CI of the seasonal transmission potential of 1.2 L3/person. These data, assumed to be representative of the focus as a whole, suggest that there is no ongoing transmission of Onchocerca volvulus in the northern Chiapas focus. Community-wide treatments with ivermectin were halted in 2008, and a post-treatment surveillance phase was initiated.

Citing Articles

Changes in Anti-OV-16 IgG4 Responses to Onchocerciasis after Elimination of Transmission in the Central Endemic Zone of Guatemala.

Cama V, Mendizabal-Cabrera R, de Leon O, White M, McDonald C, Thiele E Am J Trop Med Hyg. 2024; 110(5):943-950.

PMID: 38507804 PMC: 11066353. DOI: 10.4269/ajtmh.23-0473.


Criteria for selecting sentinel unit locations in a surveillance system for vector-borne disease: A decision tool.

Guillot C, Bouchard C, Aenishaenslin C, Berthiaume P, Milord F, Leighton P Front Public Health. 2022; 10:1003949.

PMID: 36438246 PMC: 9686450. DOI: 10.3389/fpubh.2022.1003949.


Historical Review and Cost-Effectiveness Assessment of the Programs to Eliminate Onchocerciasis and Trachoma in Mexico.

Fernandez-Santos N, Prado-Velasco F, Damian-Gonzalez D, Unnasch T, Rodriguez-Perez M Res Rep Trop Med. 2021; 12:235-245.

PMID: 34737667 PMC: 8558426. DOI: 10.2147/RRTM.S317993.


Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis.

Coffeng L, Stolk W, Golden A, de Los Santos T, Domingo G, de Vlas S Am J Epidemiol. 2019; 188(9):1723-1732.

PMID: 31062838 PMC: 6735885. DOI: 10.1093/aje/kwz109.


Operational Performance of the "OEPA" Ov16 ELISA Serological Assay in Mapping, Guiding Decisions to Stop Mass Drug Administration, and Posttreatment Surveillance Surveys.

Richards F, Katabarwa M, Bekele F, Tadesse Z, Mohammed A, Sauerbrey M Am J Trop Med Hyg. 2018; 99(3):749-752.

PMID: 30014821 PMC: 6169192. DOI: 10.4269/ajtmh.18-0341.


References
1.
Lipner E, Dembele N, Souleymane S, Alley W, Prevots D, Toe L . Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis. 2006; 194(2):216-21. DOI: 10.1086/505081. View

2.
Collins R, Ochoa J, Cupp E, PORTER C . Microepidemiology of onchocerciasis in Guatemala: dispersal and survival of Simulium ochraceum. Am J Trop Med Hyg. 1992; 47(2):147-55. DOI: 10.4269/ajtmh.1992.47.147. View

3.
Rodriguez-Perez M . [The effect of ivermectin on the transmission of Onchocerca volvulus in southern Mexico]. Salud Publica Mex. 1994; 36(3):281-90. View

4.
Rodriguez-Perez M, Rodriguez M . Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico. Am J Trop Med Hyg. 1995; 52(5):429-34. View

5.
Katholi C, Toe L, Merriweather A, Unnasch T . Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J Infect Dis. 1995; 172(5):1414-7. DOI: 10.1093/infdis/172.5.1414. View